Xinlikang capsule for fatigue after lymphoma treatment
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a Chinese herbal capsule, Xinlikang, to see if it helps reduce fatigue and improve immune function after chemotherapy for diffuse large B-cell lymphoma. It is for people who have finished their first treatment and still feel very tired.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been newly diagnosed with diffuse large B-cell lymphoma (DLBCL) and have completed your first round of chemotherapy and immunotherapy.
- You have significant fatigue (rated 4 or more on a 0-10 scale) after finishing treatment.
- You are not planning to receive other cancer treatments (like radiation, chemo, or other drugs) for the next 3 months.
- You do not have serious liver, kidney, or bone marrow problems, active infections, or other cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new supplement called CP003 to see if it helps reduce tiredness in people with chronic fatigue syndrome or long COVID fatigue.
This trial studies how Maixuekang capsules are processed in the body of healthy adults. It looks at the drug's levels over time to make sure it works safely.
This trial tests a traditional Chinese medicine, Zhengyuan Capsules, to see if it helps reduce cancer-related fatigue in breast cancer survivors. You may qualify if your fatigue is moderate to severe and you have finished your main treatments at least two months ago.
This study tests if eating more fruits and vegetables can help reduce persistent fatigue in people with lymphoma. You will receive questionnaires by email to track your fatigue and diet over time.
This study is testing whether a natural herbal supplement called FL Nourish Capsules is safe for people who have had cancer and are now in remission. It focuses on those with a Traditional Chinese Medicine pattern of Qi deficiency and Blood stasis, which may cause tiredness and poor circulation.
This trial tests Ganzhixiao capsules for people with MAFLD (a type of fatty liver disease) who also have symptoms of 'damp heat' (like feeling heavy and sluggish). It aims to see if the capsules can help improve liver health.
Hear when a new Diffuse Large B-Cell Lymphoma (DLBCL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.